Quantificação de carbamazepina, fluoxetina e seus metabólitos principais em leite materno por injeção direta de amostra utilizando cromatografia líquida acoplada à espectrometria de massa

Abstract

This work reports the application of bioanalitycal methods by direct injection sample for the quantification of drugs in breast milk. Columns with stationary phase type RAM-BSA, in conventional scale and microbore, were prepared and evaluated in the exclusion of total protein and human milk oligosaccharides. In the conventional scale, the RAM-BSA C18 column (4.6 mm id) was used in a single-column mode for cleanup and simultaneous quantification of carbamazepine and its major metabolite, employing an analyzer of the type ion trap. Selectivity, extraction efficiency, accuracy and precision were achieved employing 100 μL of the sample, without preparation, with detection limits of 20.0 ng/mL for CBZ and 40.0 ng/mL for CBZE. The developed method was validated and applied to analyze breast milk samples from one nursing mother. CBZ and CBZE were quantified in the concentrations of 2.26 μg/mL and 1.54 μg/mL, respectively. To our knowledge, this is the first report on the simultaneous determination of CBZ and its active metabolite by direct injection of human milk serum. The method for quantification of fluoxetine and norfluoxetine by direct injection of nature human milk employing a liquid chromatography tandem mass spectrometry system was performed in a multidimensional system with total analysis time of 12 min. The chromatographic system was configured using a RAM-BSA C18 (2.1 mm, i.d.) column in the first dimension that was able to excluded 94% of proteins. A fused core column was used in the the second dimension as analytical column. Selectivity, extraction efficiency, accuracy and precision were achieved employing 10 μL of the sample, without sample clean-up, with quantification limits of 3.0 ng/mL and 4.0 ng/mL for FLU and NOR, respectively.